Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis

Antifibrotic agents have been widely used in patients with idiopathic pulmonary fibrosis (IPF). Long-term continuation of antifibrotic therapy is required for IPF treatment to prevent disease progression. However, antifibrotic treatment has considerable adverse events, and the continuation of treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Takehara, Kazutaka, Koga, Yasuhiko, Hachisu, Yoshimasa, Utsugi, Mitsuyoshi, Sawada, Yuri, Saito, Yasuyuki, Yoshimi, Seishi, Yatomi, Masakiyo, Shin, Yuki, Wakamatsu, Ikuo, Umetsu, Kazue, Kouno, Shunichi, Nakagawa, Junichi, Sunaga, Noriaki, Maeno, Toshitaka, Hisada, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750555/
https://www.ncbi.nlm.nih.gov/pubmed/35011705
http://dx.doi.org/10.3390/cells11010143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750555/
https://www.ncbi.nlm.nih.gov/pubmed/35011705
http://dx.doi.org/10.3390/cells11010143

Ejemplares similares